140 related articles for article (PubMed ID: 28472014)
1. Protection by the Eph-Ephrin System Against Mesenteric Ischemia-Reperfusion Injury.
Vivo V; Zini I; Cantoni AM; Grandi A; Tognolini M; Castelli R; Ballabeni V; Bertoni S; Barocelli E
Shock; 2017 Dec; 48(6):681-689. PubMed ID: 28472014
[TBL] [Abstract][Full Text] [Related]
2. UniPR1331: Small Eph/Ephrin Antagonist Beneficial in Intestinal Inflammation by Interfering with Type-B Signaling.
Giorgio C; Allodi M; Palese S; Grandi A; Tognolini M; Castelli R; Lodola A; Flammini L; Cantoni AM; Barocelli E; Bertoni S
Pharmaceuticals (Basel); 2021 May; 14(6):. PubMed ID: 34074058
[TBL] [Abstract][Full Text] [Related]
3. Upregulation of EphA2 during in vivo and in vitro renal ischemia-reperfusion injury: role of Src kinases.
Baldwin C; Chen ZW; Bedirian A; Yokota N; Nasr SH; Rabb H; Lemay S
Am J Physiol Renal Physiol; 2006 Nov; 291(5):F960-71. PubMed ID: 16735461
[TBL] [Abstract][Full Text] [Related]
4. EPHA4-FC TREATMENT REDUCES ISCHEMIA/REPERFUSION-INDUCED INTESTINAL INJURY BY INHIBITING VASCULAR PERMEABILITY.
Woodruff TM; Wu MC; Morgan M; Bain NT; Jeanes A; Lipman J; Ting MJ; Boyd AW; Taylor SM; Coulthard MG
Shock; 2016 Feb; 45(2):184-91. PubMed ID: 26771935
[TBL] [Abstract][Full Text] [Related]
5. Ligation of EphA2 by Ephrin A1-Fc inhibits pancreatic adenocarcinoma cellular invasiveness.
Duxbury MS; Ito H; Zinner MJ; Ashley SW; Whang EE
Biochem Biophys Res Commun; 2004 Aug; 320(4):1096-102. PubMed ID: 15249202
[TBL] [Abstract][Full Text] [Related]
6. EphrinA1-Fc Attenuates Ventricular Remodeling and Dysfunction in Chronically Nonreperfused WT but not EphA2-R-M mice.
Whitehurst KS; Chan VA; Estes HK; Valsaraj S; Kent S; Sharma UM; Chase RC; Bhuiyan M; Virag JAI
Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32823610
[TBL] [Abstract][Full Text] [Related]
7. Eph/ephrin signalling serves a bidirectional role in lipopolysaccharide‑induced intestinal injury.
Xiong Y; Li KX; Wei H; Jiao L; Yu SY; Zeng L
Mol Med Rep; 2018 Aug; 18(2):2171-2181. PubMed ID: 29901151
[TBL] [Abstract][Full Text] [Related]
8. C1GALT1 is associated with poor survival and promotes soluble Ephrin A1-mediated cell migration through activation of EPHA2 in gastric cancer.
Lee PC; Chen ST; Kuo TC; Lin TC; Lin MC; Huang J; Hung JS; Hsu CL; Juan HF; Lee PH; Huang MC
Oncogene; 2020 Mar; 39(13):2724-2740. PubMed ID: 32005975
[TBL] [Abstract][Full Text] [Related]
9. Activation of erythropoietin-producing hepatocellular receptor A2 attenuates cell adhesion of human fallopian tube epithelial cells via focal adhesion kinase dephosphorylation.
Yang XY; Zhu WJ; Jiang H
Mol Cell Biochem; 2012 Feb; 361(1-2):259-65. PubMed ID: 22009484
[TBL] [Abstract][Full Text] [Related]
10. Eph-A2 promotes permeability and inflammatory responses to bleomycin-induced lung injury.
Carpenter TC; Schroeder W; Stenmark KR; Schmidt EP
Am J Respir Cell Mol Biol; 2012 Jan; 46(1):40-7. PubMed ID: 21799118
[TBL] [Abstract][Full Text] [Related]
11. Ephrin-A1-mediated dopaminergic neurogenesis and angiogenesis in a rat model of Parkinson's disease.
Jing X; Miwa H; Sawada T; Nakanishi I; Kondo T; Miyajima M; Sakaguchi K
PLoS One; 2012; 7(2):e32019. PubMed ID: 22363788
[TBL] [Abstract][Full Text] [Related]
12. Bifunctional role of ephrin A1-Eph system in stimulating cell proliferation and protecting cells from cell death through the attenuation of ER stress and inflammatory responses in bovine mammary epithelial cells.
Kang M; Jeong W; Bae H; Lim W; Bazer FW; Song G
J Cell Physiol; 2018 Mar; 233(3):2560-2571. PubMed ID: 28777434
[TBL] [Abstract][Full Text] [Related]
13. Biological and structural characterization of glycosylation on ephrin-A1, a preferred ligand for EphA2 receptor tyrosine kinase.
Ferluga S; Hantgan R; Goldgur Y; Himanen JP; Nikolov DB; Debinski W
J Biol Chem; 2013 Jun; 288(25):18448-57. PubMed ID: 23661698
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of EphA2 by Dasatinib Suppresses Radiation-Induced Intestinal Injury.
Kim A; Seong KM; Choi YY; Shim S; Park S; Lee SS
Int J Mol Sci; 2020 Nov; 21(23):. PubMed ID: 33265912
[TBL] [Abstract][Full Text] [Related]
15. EphrinA1-Fc attenuates myocardial ischemia/reperfusion injury in mice.
DuSablon A; Parks J; Whitehurst K; Estes H; Chase R; Vlahos E; Sharma U; Wert D; Virag J
PLoS One; 2017; 12(12):e0189307. PubMed ID: 29236774
[TBL] [Abstract][Full Text] [Related]
16. EphrinA1-induced cytoskeletal re-organization requires FAK and p130(cas).
Carter N; Nakamoto T; Hirai H; Hunter T
Nat Cell Biol; 2002 Aug; 4(8):565-73. PubMed ID: 12134157
[TBL] [Abstract][Full Text] [Related]
17. Tiam1 mediates neurite outgrowth induced by ephrin-B1 and EphA2.
Tanaka M; Ohashi R; Nakamura R; Shinmura K; Kamo T; Sakai R; Sugimura H
EMBO J; 2004 Mar; 23(5):1075-88. PubMed ID: 14988728
[TBL] [Abstract][Full Text] [Related]
18. Targeting EphA2 in cancer.
Xiao T; Xiao Y; Wang W; Tang YY; Xiao Z; Su M
J Hematol Oncol; 2020 Aug; 13(1):114. PubMed ID: 32811512
[TBL] [Abstract][Full Text] [Related]
19. EphA kinase activation regulates HGF-induced epithelial branching morphogenesis.
Miao H; Nickel CH; Cantley LG; Bruggeman LA; Bennardo LN; Wang B
J Cell Biol; 2003 Sep; 162(7):1281-92. PubMed ID: 14517207
[TBL] [Abstract][Full Text] [Related]
20. Human dendritic cells express neuronal Eph receptor tyrosine kinases: role of EphA2 in regulating adhesion to fibronectin.
de Saint-Vis B; Bouchet C; Gautier G; Valladeau J; Caux C; Garrone P
Blood; 2003 Dec; 102(13):4431-40. PubMed ID: 12907451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
